within Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G01A_AntiinfectivesAndAntisepticsExclCombinationsWith.G01AF06_Ornidazole;

model Ornidazole
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.9,
    Cl = 1.0833333333333333e-06,
    adminDuration = 600,
    adminMass = 500 / 1000000,
    adminCount = 1,
    Vd = 0.044,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.02033333333333333,
    Tlag = 10.200000000000001);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Ornidazole</td></tr><tr><td>ATC code:</td><td>G01AF06</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>500</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>44.0</td><td>L</td></tr>
    <tr><td>clearance:</td><td>3.9</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Ornidazole is a nitroimidazole antimicrobial agent used primarily for the treatment of protozoal infections and anaerobic bacterial infections. It is structurally related to metronidazole and is active against Giardia lamblia, Entamoeba histolytica, and Trichomonas vaginalis, as well as various anaerobic bacteria. Ornidazole is approved for clinical use in several countries, though not in all regions worldwide.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after a single oral dose.</p><h4>References</h4><ol><li><p>Cao, Y, et al., &amp; Wu, H (2023). Population pharmacokinetics of levornidazole in healthy subjects and patients, and sequential dosing regimen proposal using pharmacokinetic/pharmacodynamic analysis. <i>International journal of antimicrobial agents</i> 61(4) 106754–None. DOI:<a href=\"https://doi.org/10.1016/j.ijantimicag.2023.106754\">10.1016/j.ijantimicag.2023.106754</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/36773938/\">https://pubmed.ncbi.nlm.nih.gov/36773938</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.G.G01AF06 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Ornidazole;
